IRAK4-IN-3
- Product Name
- IRAK4-IN-3
- CAS No.
- 2196204-23-4
- Chemical Name
- IRAK4-IN-3
- Synonyms
- AZ1495;IRAK4-IN-3;AZ1495 ,E2647;AZ1495, 10 mM in DMSO;N-(trans-4-Morpholinocyclohexyl)-5-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;N-((1r,4r)-4-morpholinocyclohexyl)-5-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-[trans-4-(4-morpholinyl)cyclohexyl]-5-(tetrahydro-2H-pyran-4-yl)-;N-((1R,4R)-4-Morpholin-4-ylcyclohexyl)-5-(tetrahydro-2H-pyran-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-ylamine;AZ-1495,Interleukin-1 receptor associated kinase,interleukin-1 receptor associated kinase 4 (IRAK4),AZ1495,inhibit,cancer,IL-1R associated kinase,AZ 1495,weak base,IRAK,diffuse large B-cell lymphoma (DLBCL),Inhibitor,interleukin-1 receptor associated kinase 1 (IRAK1)
- CBNumber
- CB74818343
- Molecular Formula
- C21H31N5O2
- Formula Weight
- 385.5
- MOL File
- 2196204-23-4.mol
IRAK4-IN-3 Property
- Density
- 1.265±0.06 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO : 10 mg/mL (25.94 mM)
- form
- Solid
- pka
- 13.07±0.50(Predicted)
- color
- White to off-white
N-Bromosuccinimide Price
- Product number
- CS-0034227
- Product name
- AZ1495
- Purity
- 99.83%
- Packaging
- 5mg
- Price
- $550
- Updated
- 2021/12/16
- Product number
- CS-0034227
- Product name
- AZ1495
- Purity
- 99.83%
- Packaging
- 10mg
- Price
- $850
- Updated
- 2021/12/16
- Product number
- CS-0034227
- Product name
- AZ1495
- Purity
- 99.83%
- Packaging
- 25mg
- Price
- $1750
- Updated
- 2021/12/16
- Product number
- CS-0034227
- Product name
- AZ1495
- Purity
- 99.83%
- Packaging
- 50mg
- Price
- $2750
- Updated
- 2021/12/16
- Product number
- CS-0034227
- Product name
- AZ1495
- Purity
- 99.83%
- Packaging
- 100mg
- Price
- $3950
- Updated
- 2021/12/16
IRAK4-IN-3 Chemical Properties,Usage,Production
Uses
AZ1495, a weak base, is a potent orally active interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor. AZ1495 has a favorable physicochemical and kinase selectivity for IRAK4 and IRAK1 with IC50 values of 0.005 μM and 0.023 μM, respectively. AZ1495 has IRAK4 inhibition with a Kd value of 0.0007 μM. AZ1495 can be used for the research of diffuse large B-cell lymphoma (DLBCL)[1].
in vivo
AZ1495 (compound 28) (oral, daily, 12.5 mg/kg) leds to tumor regression combination with ibrutinib in an ABC-DLBCL mouse model (OCI-LY10 cells)[1].
AZ1495 (iv., 2 mg/kg and oral, 5mg/kg) is characterized by high clearance (Cl) in rat (75 mL/min/kg) and moderate predictions based on hepatocyte data (Clint 15 μl/min/106 cells, predicted clearance 42 mL/min/kg) with low bioavailability consistent with a high first pass effect[1].
AZ1495 (iv., 1 mg/kg) has low the amount of active renal secretion occurring in the dog[1].
| Animal Model: | CB.17 SCID mice[1] |
| Dosage: | 12.5 mg/kg |
| Administration: | oral, daily, 12.5 mg/kg |
| Result: | Had modest anti-tumor activity as single agents but a combination ofibrutinib led to tumor regression and is well tolerated. |
| Animal Model: | rat[1] | ||||||||||||||||||||||||
| Dosage: | 2 mg/kg, 5mg/kg | ||||||||||||||||||||||||
| Administration: | iv., 2 mg/kg and oral, 5mg/kg | ||||||||||||||||||||||||
| Result: |
|
| Animal Model: | dog[1] | ||||||||||||||||||||||||
| Dosage: | 1 mg/kg | ||||||||||||||||||||||||
| Administration: | iv., 1 mg/kg | ||||||||||||||||||||||||
| Result: |
|
IC 50
IRAK4: 5 nM (IC50); IRAK1: 23 nM (IC50); CLK1: 50 nM (IC50); CLK2: 5 nM (IC50); CLK4: 8 nM (IC50); haspin: 4 nM (IC50)
References
[1] Scott JS, et al. Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma. J Med Chem. 2017 Dec 28;60(24):10071-10091. DOI:10.1021/acs.jmedchem.7b01290
IRAK4-IN-3 Preparation Products And Raw materials
Raw materials
Preparation Products
IRAK4-IN-3 Suppliers
- Tel
- 025-83697070 13913916777
- Fax
- +86-25-83453306
- info@chemlin.com.cn
- Country
- China
- ProdList
- 16027
- Advantage
- 64
- Tel
- 15026594951
- Fax
- 0556-5030632
- rs@raise-chem.com
- Country
- China
- ProdList
- 4677
- Advantage
- 55
- Tel
- 400-400-164-7117 18317119277
- Fax
- +86-21-61629029
- product02@bidepharm.com
- Country
- China
- ProdList
- 40000
- Advantage
- 60
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4817
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 86249
- Advantage
- 60
- Tel
- 15911056312
- liming@bio-fount.com
- Country
- China
- ProdList
- 9729
- Advantage
- 58
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32467
- Advantage
- 58
- Tel
- +1-631-485-4226
- Fax
- 1-631-614-7828
- inquiry@bocsci.com
- Country
- United States
- ProdList
- 19552
- Advantage
- 58
- Tel
- 18818260767
- Fax
- QQ 3610331285
- sales@chemegen.com
- Country
- China
- ProdList
- 11218
- Advantage
- 58